LIP SCC

Clinical trials for LIP SCC explained in plain language.

Never miss a new study

Get alerted when new LIP SCC trials appear

Sign up with your email to follow new studies for LIP SCC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New combo therapy shows promise for Tough-to-Treat head and neck cancer

Disease control Completed

This study tested a combination of two drugs, pembrolizumab and cetuximab, in 78 people with advanced head and neck cancer that had come back or spread. Participants were grouped based on whether they had tried these drugs before. The goal was to see if the combination could shri…

Matched conditions: LIP SCC

Phase: PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control

Last updated May 17, 2026 04:18 UTC

LIP SCC

Get alerted when new LIP SCC trials appear

New combo therapy shows promise for Tough-to-Treat head and neck cancer